about
Circulating Anti-Elastin Antibody Levels and Arterial Disease Characteristics: Associations with Arterial Stiffness and AtherosclerosisA paclitaxel-eluting stent for the prevention of coronary restenosisAngiographic and intravascular ultrasound follow up of paclitaxel- and sirolimus-eluting stent after poststent high-pressure balloon dilation: from the poststent optimal stent expansion trial.Impact of family history on the presentation and clinical outcomes of coronary heart disease: data from the Korea Acute Myocardial Infarction Registry.Effects of Intravascular Ultrasound-Guided Versus Angiography-Guided New-Generation Drug-Eluting Stent Implantation: Meta-Analysis With Individual Patient-Level Data From 2,345 Randomized Patients.Percutaneous transabdominal approach for the treatment of endoleaks after endovascular repair of infrarenal abdominal aortic aneurysmLong-Term clinical outcomes according to initial management and thrombolysis in myocardial infarction risk score in patients with acute non-ST-segment elevation myocardial infarction.The initial extent of malapposition in ST-elevation myocardial infarction treated with drug-eluting stent: the usefulness of optical coherence tomography.Association of plasma retinol-binding protein 4, adiponectin, and high molecular weight adiponectin with insulin resistance in non-diabetic hypertensive patientsOptical coherence tomographic observation of morphological features of neointimal tissue after drug-eluting stent implantationPercutaneous cardiopulmonary support in refractory no-reflow with cardiogenic shock after coronary stenting in acute myocardial infarction.Multidisciplinary team approach for identifying potential candidate for transcatheter aortic valve implantationIsolated noncompaction of the ventricular myocardium: contrast echocardiographic findings and review of the literature.Impact of statin treatment on strut coverage after drug-eluting stent implantation.Insulin Protects Cardiac Myocytes from Doxorubicin Toxicity by Sp1-Mediated Transactivation of SurvivinCardiac Usage of Reducible Poly(oligo-D-arginine) As a Gene Carrier for Vascular Endothelial Growth Factor Expression.Correlations between coronary plaque tissue composition assessed by virtual histology and blood levels of biomarkers for coronary artery disease.Comparison of optical coherence tomographic assessment between first- and second-generation drug-eluting stentsElective stent-graft treatment of aortic dissections.Comparison between measured and calculated length of side branch ostium in coronary bifurcation lesions with intravascular ultrasound.Serial plasma levels of angiogenic factors in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.Potential association between coronary artery disease and the inflammatory biomarker YKL-40 in asymptomatic patients with type 2 diabetes mellitus.The Effect of FLT1 Variant on Long-Term Cardiovascular Outcomes: Validation of a Locus Identified in a Previous Genome-Wide Association Study.Statin Intensity and Clinical Outcome in Patients with Stable Coronary Artery Disease and Very Low LDL-CholesterolImpact of Coronary Plaque Characteristics on Late Stent Malapposition after Drug-Eluting Stent ImplantationArterial occlusive disease complicating radiation therapy of cervical cancer.The Beneficial Effect of Renin-Angiotensin-Aldosterone System Blockade in Marfan Syndrome Patients after Aortic Root Replacement.Percutaneous Coronary Intervention Is More Beneficial Than Optimal Medical Therapy in Elderly Patients with Angina Pectoris.Therapeutic effects of water soluble danshen extracts on atherosclerosis.Comparison of early clinical outcomes following transcatheter aortic valve implantation versus surgical aortic valve replacement versus optimal medical therapy in patients older than 80 years with symptomatic severe aortic stenosisIncrease of metabolic syndrome score is an independent determinant of increasing pulse pressure.Endothelial nitric oxide synthase Glu298Asp gene polymorphism is associated with hypertensive response to exercise in well-controlled hypertensive patients.Early Effects of Intensive Lipid-Lowering Treatment on Plaque Characteristics Assessed by Virtual Histology Intravascular Ultrasound.Development of Advanced Atherosclerotic Plaque by Injection of Inflammatory Proteins in a Rabbit Iliac Artery Model.Efficacy and safety of fixed-dose combination therapy with olmesartan medoxomil and rosuvastatin in Korean patients with mild to moderate hypertension and dyslipidemia: an 8-week, multicenter, randomized, double-blind, factorial-design study (OLSTA-Lack of Superiority for Soluble ST2 over High Sensitive C-Reactive Protein in Predicting High Risk Coronary Artery Calcium Score in a Community CohortPrognostic usefulness of metabolic syndrome compared with diabetes in Korean patients with critical lower limb ischemia treated with percutaneous transluminal angioplastyThe Impact of Diabetes Mellitus on Vascular Biomarkers in Patients with End-Stage Renal Disease.A randomized, open-label, multicenter trial for the safety and efficacy of adult mesenchymal stem cells after acute myocardial infarction.Development of a New Hybrid Biodegradable Drug-Eluting Stent for the Treatment of Peripheral Artery Disease
P50
Q27333137-5FA9970A-EBD4-4CA6-80D8-0A8FE8ED3DCBQ28195693-071517BD-4D49-4E40-92F0-A2C2DE9D6932Q30394624-B507F813-D184-4642-A790-9C4766E65BA3Q30665284-B706E452-BD44-4BCC-AC07-D354F6455FF4Q31136894-B7529BAE-43A3-431C-AD30-C8AAD4AA7637Q33563708-F392862F-E03F-44CD-A401-07B26D9EDF4AQ33565305-A42A120E-CA34-47A5-9EBB-03381D0B500CQ33781917-F717427A-987A-45D8-9A5A-9DE193D04884Q33781951-704A9D14-59B8-4ABB-BCA0-984B4C81B3E4Q33822577-1670878D-D92C-4C38-BCCA-AF6A782BBF91Q33892291-B68F6742-790C-4F2E-8076-65BA9B7892D2Q33941588-40FA5576-FB5A-42BB-BF61-84BE91C3FD0CQ34583731-D6EE163C-F072-437F-A929-386BF7697793Q34774239-39889CB9-A219-4497-95FC-27202306B6BFQ35745202-72086EA4-62B0-4FBB-B394-7F7E414986F6Q35864050-C0087A13-314E-4310-990B-DF05D54F6ED6Q35932082-7FF49BEC-593C-4FB4-A392-4F412020C4CDQ35932110-D3826550-3D78-416B-B70F-577C4F2DA131Q35992088-183DE89E-2DE1-413F-BA5F-84C9AC1EE6C7Q36053467-941330C7-349D-471D-8F00-845DADA1E6C0Q36131400-DCE4F057-0B7B-4FFA-96E7-C9630A74AFDDQ36136647-EBC25BF9-DED9-4121-8C82-FBB1617A338EQ36162743-C3880B46-4FBC-4C51-A6AE-69F247AABFFCQ36185746-03391BE0-90F0-47FF-80E1-9E877E5AC9A4Q36240137-9F932CC2-7405-4AA5-8CCA-D69318EC72B0Q36348023-E1F09343-1261-48D5-8A85-36CF8BEE88A5Q36418768-EF8CFDA4-398A-48D5-9EB1-107CB44CB7AFQ36541569-C4855D56-259D-451C-927A-BB66FB77B0C2Q36582676-7F1BCE2A-B1E7-416F-B478-C5E2CD03857AQ36793079-0935D6D0-3A31-4E7D-B51A-9655C889AF83Q37040799-D61BDB9F-BEB0-4110-912F-ECE5A1B52791Q37065472-D4CEAE89-B920-4AD8-8B53-BE88C2278A87Q37124751-AF1E04E9-3BD2-4ED9-9D5A-79C0021AFCE1Q37124756-E8B30086-B69A-4F7A-ACCE-9675052875B5Q37194141-EFBAD40A-97D3-4823-A027-FEE840896D5CQ37231845-8E8BD494-CB80-48DE-8C8A-842CABD14A22Q37418795-31881D81-27A5-4757-98C6-1DF47EE49C61Q37438415-7F0E74E9-9584-4A9E-9646-00BB5021B844Q37473636-B14C6114-D714-4062-B9F6-FE6313229B19Q37483241-B40B2944-2F0B-4B98-89EF-0BBC8C275464
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
研究者
@zh
name
Donghoon Choi
@ast
Donghoon Choi
@en
Donghoon Choi
@es
Donghoon Choi
@nl
type
label
Donghoon Choi
@ast
Donghoon Choi
@en
Donghoon Choi
@es
Donghoon Choi
@nl
prefLabel
Donghoon Choi
@ast
Donghoon Choi
@en
Donghoon Choi
@es
Donghoon Choi
@nl
P31
P496
0000-0002-2009-9760